Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1992-12-31
1994-10-11
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
552653, H61K 3159, C07J 900
Patent
active
053547446
ABSTRACT:
This invention provides novel vitamin D-related compounds characterized by extended unsaturated side chain structures. Such compounds exhibit increased activity in arresting the proliferation and promoting the differentiation of malignant cells with only minimal calcemic activity and thus represents new therapeutic agents applicable and uniquely useful in differentiation therapy of malignant diseases. The activity characteristics of these compounds provide the basis of a method for the treatment of neoplastic diseases, specifically leukemoid diseases.
REFERENCES:
patent: 4225596 (1980-09-01), DeLuca
patent: 4230701 (1980-10-01), Holick et al.
patent: 4689180 (1987-08-01), DeLuca et al.
patent: 4717721 (1988-01-01), DeLuca et al.
CA 113: 78822r, Calverley et al., 1990.
DeLuca Hector F.
Perlman Kato L.
Schnoes Heinrich K.
Cintins Marianne M.
Jordan Kimberly R.
Wisconsin Alumni Research Foundation
LandOfFree
Side chain unsaturated 1 alpha-hydroxyvitamin D analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Side chain unsaturated 1 alpha-hydroxyvitamin D analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Side chain unsaturated 1 alpha-hydroxyvitamin D analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658700